Is Rocket Lab Stock a Buy After the SpaceX IPO?

Rocket Lab is down 6.6% since SpaceX's IPO, but the article highlights continued rapid revenue growth, narrowing EBITDA losses, and $1 billion in cash. The key catalyst is Neutron, which is expected to carry heavier payloads at a meaningful discount to Falcon 9 and could unlock higher-value contracts if it launches successfully before year-end. Valuation remains rich at about 100x sales, but the piece argues Rocket Lab may have more room to grow into its multiple than SpaceX.

Analysis

This is less a broad “space rally” than a dispersion event: the market is rewarding the platform with visible monetization optionality while discounting the smaller launch incumbent because its next step-function leg is binary. The key second-order effect is that a successful Neutron flight would not just add another rocket; it would re-rate the entire mix toward higher-value payloads and defense/intel customers, which is where operating leverage can arrive faster than headline revenue growth suggests.

The risk is that valuation is now being underwritten by schedule confidence rather than realized economics. With a 12-month horizon, any further Neutron delay creates a double-hit: lost credibility with customers and a compression in multiple as investors realize the current sales base is still anchored in a low-ASP launch product. Conversely, a clean launch plus early contract disclosures could catalyze a sharp multiple expansion because the market is already pricing in some success but not yet a durable conversion of that success into backlog.

The consensus is probably over-emphasizing the relative P/S versus the absolute execution gap. A lower multiple does not make the stock safer if the next 2-3 milestones are all technical; the asymmetry is that success can rerate the stock quickly, while failure likely bleeds slowly via dilution and delayed revenue recognition. For peers and adjacent winners, the real beneficiary is not another launch company but prime contractors and payload integrators that can win slots if Neutron slips again.

From a positioning standpoint, this looks better as a catalyst-driven trade than a core long at current levels. The setup favors waiting for either a confirmed launch window or a post-failure washout before adding risk, because the stock’s path dependency is high and the market is currently paying for a perfect execution path.

Key Decisions for Investors

• Do not initiate a new core long in RKLB at current levels; wait for either a confirmed Neutron launch date or a 10-15% pullback after any delay headline. Risk/reward is poor until technical execution risk de-risks.
• For aggressive accounts, buy RKLB call spreads into the launch window only if the company releases a firm schedule. A 3-6 month call spread can capture rerating on a clean flight while defining downside to premium.
• If Neutron slips again, pair trade: short RKLB against a basket of defense/space primes or launch-adjacent beneficiaries that can absorb delayed payload demand. The thesis is that contract leakage, not just sentiment, will drive relative underperformance.
• Use any successful launch catalyst to trim strength into the first post-event spike; the tradeable move is likely faster than the fundamental monetization curve, so upside can be front-loaded while execution risk remains.